Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome

Radiotherapy and Oncology

Volumn 107, Issue 1, 2013, Pages 117-122

  Andersen, Erlend K F ^a   Hole, Knut Håkon ^a,b   Lund, Kjersti V ^a   Sundfør, Kolbein ^a   Kristensen, Gunnar B ^a   Lyng, Heidi ^a   Malinen, Eirik ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cervical cancer; Contrast enhancement; Gd DTPA; MRI; Pharmacokinetic analysis; Prediction; Radiotherapy

Indexed keywords

CISPLATIN; GADOLINIUM PENTETATE MEGLUMINE;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHEMORADIOTHERAPY; CONTRAST ENHANCEMENT; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

CHEMORADIOTHERAPY; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84878219843     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.11.007     Document Type: Article

References (22)

1. L. Barbera, and G. Thomas Management of early and locally advanced cervical cancer Semin Oncol 36 2009 155 169
2. V.N. Harry Novel imaging techniques as response biomarkers in cervical cancers Gynecol Oncol 116 2010 253 261
3. M.A. Zahra, K.G. Hollingsworth, E. Sala, D.J. Lomas, and L.T. Tan Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy Lancet Oncol 8 2007 63 74
4. P.S. Tofts, G. Brix, D.L. Buckley, J.L. Evelhoch, and E. Henderson Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232
5. P.S. Tofts Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J Magn Reson Imaging 7 1997 91 101
6. E.K. Andersen, G.B. Kristensen, H. Lyng, and E. Malinen Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers Acta Oncol 50 2011 859 865
7. M.A. Zahra, L.T. Tan, A.N. Priest, M.J. Graves, and M. Arends Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer Int J Radiat Oncol Biol Phys 74 2009 766 773
8. S.I. Semple, V.N. Harry, D.E. Parkin, and F.J. Gilbert A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 75 2009 611 617
9. J.A. Loncaster, B.M. Carrington, J.R. Sykes, A.P. Jones, and S.M. Todd Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix Int J Radiat Oncol Biol Phys 54 2002 759 767
10. Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, and S. Ikeda Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy Radiology 216 2000 803 809
11. E.K. Andersen, K.H. Hole, K.V. Lund, K. Sundfor, and G.B. Kristensen Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance Int J Radiat Oncol Biol Phys 82 2012 e485 e492
12. C. Halle, E. Andersen, M. Lando, E.K. Aarnes, and G. Hasvold Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI Cancer Res 72 2012 5285 5295
13. C.B. Markwardt Non-linear least squares fitting in IDL with MPFIT Astronomical data analysis software and systems XVIII 411 2008 251 254
14. R.E. Port, M.V. Knopp, and G. Brix Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors Magn Reson Med 45 2001 1030 1038
15. N.A. Mayr, W.T. Yuh, D. Jajoura, J.Z. Wang, and S.S. Lo Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer Cancer 116 2010 903 912
16. S. Sovik, H.K. Skogmo, E.K. Andersen, O.S. Bruland, and D.R. Olsen DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis Radiother Oncol 93 2009 618 624
17. M.A. Haider, M. Milosevic, A. Fyles, I. Sitartchouk, and I. Yeung Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements Int J Radiat Oncol Biol Phys 62 2005 1100 1107
18. C. Ellingsen, T.A. Egeland, K. Gulliksrud, J.V. Gaustad, and B. Mathiesen Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging Int J Radiat Oncol Biol Phys 73 2009 838 845
19. K.M. Ovrebo, T. Hompland, B. Mathiesen, and E.K. Rofstad Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging Radiother Oncol 102 2012 429 435
20. C. Ellingsen, T.A. Egeland, K. Galappathi, and E.K. Rofstad Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology Radiother Oncol 97 2010 217 224
21. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 2007 225 239
22. T.A. Egeland, J.V. Gaustad, K. Galappathi, and E.K. Rofstad Magnetic resonance imaging of tumor necrosis Acta Oncol 50 2011 427 434